Cargando…
Bone protection by inhibition of microRNA-182
Targeting microRNAs recently shows significant therapeutic promise; however, such progress is underdeveloped in treatment of skeletal diseases with osteolysis, such as osteoporosis and rheumatoid arthritis (RA). Here, we identified miR-182 as a key osteoclastogenic regulator in bone homeostasis and...
Autores principales: | Inoue, Kazuki, Deng, Zhonghao, Chen, Yufan, Giannopoulou, Eugenia, Xu, Ren, Gong, Shiaoching, Greenblatt, Matthew B., Mangala, Lingegowda S., Lopez-Berestein, Gabriel, Kirsch, David G., Sood, Anil K., Zhao, Liang, Zhao, Baohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173760/ https://www.ncbi.nlm.nih.gov/pubmed/30291236 http://dx.doi.org/10.1038/s41467-018-06446-0 |
Ejemplares similares
-
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016) -
MicroRNA therapeutics: principles, expectations, and challenges
por: Rupaimoole, Rajesha, et al.
Publicado: (2011) -
microRNA Therapeutics in Cancer — An Emerging Concept
por: Shah, Maitri Y., et al.
Publicado: (2016) -
Def6 regulates endogenous type-I interferon responses in osteoblasts and suppresses osteogenesis
por: Deng, Zhonghao, et al.
Publicado: (2020) -
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
por: Rupaimoole, Rajesha, et al.
Publicado: (2016)